BIOS Fund I, LP → ACTUATE THERAPEUTICS, INC. ACTU

Stake: 49.80% Shares: 10,267,232 CUSIP: 005083100 Class: Common Stock, par value $0.000001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 24/100 · Filer 90d Win Rate: 100% · Hist. 90d Edge: +11.6%

Passive Schedule 13G filer baseline
High conviction ownership stake (49.8%)
4 NPORT-P mutual funds holding CUSIP
Moderate short days-to-cover (4.7 DTC)
Short interest building (+40.4% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.71

1,867,593 shares short · +40.4% vs prior

Post-Filing Returns · since 2025-06-27 on ACTU

+1 day

+2.5%

+5 days

+13.1%

+30 days

+15.1%

+60 days

+37.4%

+90 days

+11.6%

+180 days

+10.1%

Anchor price 5.96 on closest trading day on/after 2025-06-27. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →